# Wernicke–Korsakoff Syndrome a Rare Complication of Hyperemesis Gravidarum: Case Report

**Authors:** Ayush Neupane, Anil Shahi, Bishaka Adhikari

PMC · DOI: 10.1002/ccr3.72065 · Clinical Case Reports · 2026-02-18

## TL;DR

A pregnant woman with severe vomiting developed Wernicke–Korsakoff syndrome and recovered after intensive treatment including high-dose thiamine.

## Contribution

This case report highlights the rare but severe neurological complication of hyperemesis gravidarum and emphasizes the importance of early thiamine treatment.

## Key findings

- A 34-year-old pregnant woman presented with full clinical features of Wernicke–Korsakoff syndrome due to hyperemesis gravidarum.
- High-dose intravenous thiamine and ICU care led to significant recovery of neuropsychiatric symptoms.
- Early diagnosis and multidisciplinary treatment prevented irreversible neurological injury in this case.

## Abstract

Hyperemesis gravidarum‐induced Wernickes–Korsakoff syndrome (WKS) is an uncommon but potentially devastating disorder in pregnancy characterized by oculomotor abnormalities, cerebellar dysfunction, and either an altered mental state or mild memory impairment. However, most cases may not display the full spectrum of clinical abnormalities, we report a 34‐year‐old woman at 15 weeks of gestation who presented with all typical features of WKS, which includes worsening confusion, an unsteady gait, visual symptoms, and episodes of disorientation after two months of relentless vomiting. Clinical evaluation revealed dehydration, horizontal nystagmus, early papilledema, and biochemical evidence of malnutrition. MRI confirmed the diagnosis of WE. She responded to high‐dose intravenous thiamine, electrolyte replacement, nutritional support, and ICU‐level care. Neuropsychiatric symptoms, including impaired concentration, recent memory loss, and hallucinations, gradually resolved. She was discharged in stable condition after 26 days and demonstrated significant recovery with a normal fetal scan at follow‐up. This case highlights the timely need for multidisciplinary treatment modalities and high‐dose thiamine supplementation in pregnant women with severe hyperemesis to prevent irreversible neurological injury.

## Linked entities

- **Chemicals:** thiamine (PubChem CID 1130)
- **Diseases:** Wernicke–Korsakoff syndrome (MONDO:0010198), hyperemesis gravidarum (MONDO:0006791)

## Full-text entities

- **Genes:** TKT (transketolase) [NCBI Gene 7086] {aka HEL-S-48, HEL107, SDDHD, TK, TKT1}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** neurological disorder (MESH:D009461), cerebellar dysfunction (MESH:D002526), impaired concentration (MESH:C567712), vomiting (MESH:D014839), neurological diseases (MESH:D020271), horizontal nystagmus (MESH:D009759), acute kidney injury (MESH:D058186), oculomotor abnormalities (MESH:D015840), confusion (MESH:D003221), hyperthyroidism (MESH:D006980), addiction (MESH:D019966), tinnitus (MESH:D014012), neuropsychiatric sequelae (MESH:D001523), neurotoxicity (MESH:D020258), weakness (MESH:D018908), cancer (MESH:D009369), WE (MESH:D014899), neurological complications (MESH:D002493), meningeal irritation (MESH:D008580), electrolyte (MESH:D014883), anxiety (MESH:D001007), ophthalmoparesis (MESH:D009886), papilledema (MESH:D010211), headache (MESH:D006261), liver disease (MESH:D008107), blurring of vision (MESH:D014786), hypomagnesemia (OMIM:613882), Korsakoff psychosis (MESH:D020915), memory impairment (MESH:D008569), NVP (MESH:D020250), hypokalemia (MESH:D007008), anorexia nervosa (MESH:D000856), loss of appetite (MESH:D001068), abortion (MESH:D000026), Chronic alcoholism (MESH:D006519), HG (MESH:D006939), dehydrated (MESH:D003681), weight loss (MESH:D015431), dizziness (MESH:D004244), auditory and visual hallucinations (MESH:D006212), Thiamine deficiency (MESH:D013832), Brain lesions (MESH:D001927), neurological injury (MESH:D020196), ataxia (MESH:D001259), malnutrition (MESH:D044342), immunodeficiency syndromes (MESH:D007153)
- **Chemicals:** ketone bodies (MESH:D007657), blood sugar (MESH:D001786), water (MESH:D014867), lactate (MESH:D019344), bilirubin (MESH:D001663), pyruvate (MESH:D019289), haloperidol (MESH:D006220), potassium chloride (MESH:D011189), metoclopramide (MESH:D008787), ranitidine (MESH:D011899), glucose (MESH:D005947), creatinine (MESH:D003404), ondansetron (MESH:D017294), magnesium (MESH:D008274), citric acid (MESH:D019343), urea (MESH:D014508), ceftriaxone (MESH:D002443), Thiamine (MESH:D013831), MGSO4 (MESH:D008278), carbohydrate (MESH:D002241), potassium (MESH:D011188), sodium (MESH:D012964)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916254/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916254/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916254/full.md

---
Source: https://tomesphere.com/paper/PMC12916254